Unjha Formulations Share Price
UNJHAFOR
Live Unjha Formulations Share Price Chart
Unjha Formulations Performance
Days Range
| Previous Close | ₹27.50 |
|---|---|
| Open | ₹28.7 |
| Volume | 17,745 |
| Day's Range | ₹27.49 - ₹28.70 |
|---|---|
| 52W Range | ₹17.52 - ₹29.50 |
| Market Cap | ₹12.32 Cr |
Unjha Formulations Fundamentals
| ROCE(TTM) | 25.02 |
|---|---|
| P/E Ratio (TTM) | 26.19 |
| P/B Ratio | 3.21 |
| Industry P/E | 50.37 |
| Debt to Equity | N/A |
| ROE | 18.34 |
| EPS (TTM) | 1.05 |
| Dividend Yield | N/A |
| Book Value | 8.58 |
| Face Value | 10 |
| ROCE(TTM) | 25.02 |
|---|---|
| P/E Ratio (TTM) | 26.19 |
| P/B Ratio | 3.21 |
| Industry P/E | 50.37 |
| Debt to Equity | N/A |
| ROE | 18.34 |
|---|---|
| EPS (TTM) | 1.05 |
| Dividend Yield | N/A |
| Book Value | 8.58 |
| Face Value | 10 |
Unjha Formulations Financials
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Net Sales | 4.29 | 4.41 | 3.28 | 3.31 |
| Expenses | 3.53 | 4.20 | 3.82 | 3.15 |
| Profit before tax | 0.82 | 0.24 | -0.49 | 0.16 |
| Operating Profit | 0.82 | 0.24 | -0.74 | 0.16 |
| Net Profit | 0.82 | 0.24 | -0.74 | 0.16 |
| EPS in Rs | 1.83 | 0.53 | -1.66 | 0.35 |
Unjha Formulations Shareholding Pattern
Promoters
36.92%
Retail And Others
63.08%
Foreign Institutional Investors
0.00%
Domestic Institutional Investors
0.00%
About Unjha Formulations
Unjha Formulations was established in Jun.'87 as a partnership firm for manufacturing pharmaceutical formulations in the Mehsana district of Gujarat. It was promoted by Shambhubhai A Patel.
The company manufactures pharmaceutical formulations like liquids, powder, tablets, capsules, injectibles, etc. It is one of the largest manufacturers of isabgul products in India. The company's products are classified under two divisions -- human consumption and veterinary products.
Company launched four new products viz.Bericof, Protobal-NT, Formentin Tablets and Nalizole in the year 1997-98.
The Company commenced its commercial production and was successfully expanding its customer base throughout the Country including U.P. Territory. Company also interested on development of Export Markets for Ferrous Sulphate, Albendazole Bolus and Iron Folic Tablets to supplement the present law domestic demand situation and achieved export turnover of Rs.0.98 during the year 1997-98.
The Company has made manufacturing agreement with Nicholas Piramal India Limited, Mumbai for sale of Isabgol Husk based Product "FYBOGEL".The company received a confirm export order worth Rs.30.00 lacs.
Parent Organisation
Indian Private
Managing Director
Krutiben M Patel
Founded
1994
NSE Symbol
Top Mutual Funds Invested in Unjha Formulations Share
Data is not available currently. Please check back later.
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,884.5 2.50 (0.13%) | ₹4,51,674.81 | 1,548.0 - 2,046.9 |
| Divis Laboratories Ltd | 8,553.5 72.00 (0.85%) | ₹2,25,515.56 | 5,636.5 - 8,674.0 |
| Torrent Pharmaceuticals Ltd | 4,977.0 77.00 (1.57%) | ₹1,86,190.07 | 3,480.6 - 5,250.0 |
| Cipla Ltd | 1,432.0 0.50 (0.03%) | ₹1,15,523.00 | 1,165.7 - 1,673.0 |
| Zydus Lifesciences Ltd | 1,116.2 -15.30 (-1.35%) | ₹1,12,917.43 | 835.5 - 1,205.0 |
| Lupin Ltd | 2,220.5 -38.50 (-1.70%) | ₹1,03,297.97 | 1,875.0 - 2,529.5 |
Popular Stocks
Unjha Formulations Ltd FAQs
Can I buy Unjha Formulations Ltd (Unjha Formulations Ltd) from Angel One?
Yes, You can buy Unjha Formulations Ltd (Unjha Formulations Ltd) shares by opening a Demat account with Angel One.
How do I buy Unjha Formulations Ltd (Unjha Formulations Ltd) from Angel One?
Unjha Formulations Ltd (Unjha Formulations Ltd) share can be bought through the following modes:
1. Direct investment: You can buy Unjha Formulations Ltd (Unjha Formulations Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Unjha Formulations Ltd (Unjha Formulations Ltd) shares.
1. Direct investment: You can buy Unjha Formulations Ltd (Unjha Formulations Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Unjha Formulations Ltd (Unjha Formulations Ltd) shares.
